Metropolitan Life Insurance Company (MetLife)’s BioAtla BCAB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-52	Closed	-$7.76K	–	2404
2023 Q2	$7.76K	Buy	+52	New	+$8.94K	﹤0.01%	2408
2022 Q1	–	Sell	-80	Closed	-$78.1K	–	2290
2021 Q4	$78.1K	Hold	80	–	–	﹤0.01%	2601
2021 Q3	$117K	Buy	80 +9	+13%	+$17.5K	﹤0.01%	2436
2021 Q2	$151K	Sell	71 -2	-3%	-$4.52K	﹤0.01%	2358
2021 Q1	$185K	Buy	+73	New	+$187K	﹤0.01%	2072

Other funds holding BCAB

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s BCAB Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of BioAtla (BCAB) in Q3 2023, closing a stake of 52 shares — an estimated $7.76K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BCAB in Q1 2021 and held it in 5 quarters. The position peaked at $185K in Q1 2021. 82 funds tracked by Wall St. Rank hold BCAB as of Q3 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining BioAtla position as of Q3 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 52 BioAtla shares in Q3 2023, an estimated $7.76K.
Metropolitan Life Insurance Company (MetLife) first reported a position in BioAtla in Q1 2021 and held it in 5 quarters.
Metropolitan Life Insurance Company (MetLife)'s BioAtla position peaked at $185K in Q1 2021.
82 funds tracked by Wall St. Rank held BioAtla as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.